INHIBITION OF ENDOTHELIAL-CELL CLEARANCE OF ATRIAL-NATRIURETIC-PEPTIDE BY CYCLIC-GMP TREATMENT

被引:14
作者
KATO, J
OEHLENSCHLAGER, WF
NEWMAN, WH
CURRIE, MG
机构
[1] MONSANTO CORP RES,MOLEC PHARMACOL,ST LOUIS,MO 63167
[2] MED UNIV S CAROLINA,DEPT CELL & MOLEC PHARMACOL & EXPTL THERAPEUT,CHARLESTON,SC 29425
关键词
D O I
10.1016/S0006-291X(05)80161-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a previous study, we reported that cyclic GMP (cGMP) selectively down-regulates the clearance receptor (C-receptor) for atrial natriuretic peptide (ANP) in the cultured bovine pulmonary artery endothelial (CPAE) cell line. The present study was undertaken in order to examine the effect of cGMP on the internalization of the ANP-receptor complex in CPAE cells. Maximum binding of [125I]APIII to the cells significantly decreased following the treatment with 1 mM 8-bromo-cGMP for 48 or 72 h. Scatchard analysis of the binding assay data from the treated cells showed a decrease in Bmax (616 to 411 fmol/mg protein) without a significant change in Kd. Removal of cell surface-bound APIII by acetic acid revealed that not only the surface binding, but also the internalization of APIII significantly decreased in 8-bromo-cGMP-treated cells, indicating a decrease in receptor-mediated uptake of ANP into the cells. These results suggest that cGMP regulates the clearance of ANP by vascular endothelial cells. © 1992 Academic Press, Inc.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 14 条